RPC/GUIDE Directory ↓

RICHMOND / START HERE

Richmond peptide clinic guide: how to find and check care

A plain-language map for understanding peptide care, comparing routes, and checking who is allowed to treat you in Virginia.

Red, blue, yellow and black blocks arranged on an open white grid
An abstract map of separate paths meeting at a clear grid.

MYTH

A name that sounds medical must belong to a place that treats patients.

FACT

This is a plain-language guide built from public government records, listed at the bottom of each page. It does not book appointments, prescribe, or sell medicine.

The address brought you here. The first useful answer is what this site actually does.

First, sort the word

In a peptide, a handful of amino acids sit linked in a row; proteins use those same units, only many more of them. Calling something a peptide settles nothing about whether that product is approved, lawful, or safe.

“Is it a peptide?” gets you nowhere. Ask these instead: what is it, who made it, who prescribed it, and what evidence applies to that exact product?

Three paths that are not equal

APPROVED MEDICINE

FDA-approved products exist, as of September 2026, for semaglutide (Ozempic, Wegovy) as well as for tirzepatide (Mounjaro, Zepbound).

MADE TO ORDER

A compounded medicine, as of September 2026, is mixed for a particular need instead of coming off the shelf as a finished drug; it reaches the counter with no FDA approval and no FDA review beforehand.

RESEARCH PRODUCT

As of September 2026, a chemical sold online for human use does not become a lawful treatment because its label says “research use only.”

The Richmond rule that matters first

As of September 2026, a clinician who treats you online while you are in Virginia generally needs authority to practise in Virginia, apart from narrow exceptions.

That licence can be checked before money changes hands.

ENDNOTES / THIS CHAPTER

Check the record

  1. FDA: compounding questions and answers
  2. FDA: approved drug application records
  3. FDA: research-product letter
  4. Virginia Board of Medicine: telemedicine guidance